You may be concerned about the recent declines in AI stocks such as NVDA. However, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and ...

On Thursday, Colliers International Group Inc. (NASDAQ:CIGI) announced the completion of its previously announced acquisition of Triovest Inc. This acquisition solidifies Colliers’ position as ...

According to analyst Jared Levine, Paycom Software, Inc. (NYSE:PAYC) appears to have regained its footing after a period of volatility, with management signaling a renewed focus on growth initiatives.

The cap, set in February 2018 due to governance and risk management failures, had limited the bank’s assets to $1.95 trillion. Bloomberg estimates the restriction cost Wells Fargo about $39 ...

Josh Brown, CEO of Ritholtz Wealth Management, explained in a recent program ... Munro Global Growth Small & Mid Cap Fund stated the following regarding Reddit, Inc. (NYSE:RDDT) in its Q4 2024 ...

The analysts outlined the company’s underwriting culture, management team composition, and strategy choices as top considerations for Steve Hemsley, the recently appointed CEO. Bernstein ...

Doug Clinton, Deepwater Asset Management co-founder and managing partner, said in a latest program on CNBC that the demand for AI services and applications is rising. Asked who the key ...

Alger Mid Cap Focus Fund stated the following regarding Marvell ... shares declined after management’s fiscal first-quarter revenue guidance fell short of analyst expectations.

The delisting comes after the company’s decision to exit key climate alliances and adjust its stance on energy-related fund offerings ... multinational investment management corporation and ...

This AI-powered claims management system simplifies workflows and accelerates decision-making in the insurance sector. The launch of Connected Claims 2.0 follows Everest Group naming Appian ...

BlackRock, Inc. (NYSE:BLK), an investment management company, revealed a 1.58% stake in Mural Oncology plc (NASDAQ:MURA), an Ireland-based clinical-stage oncology giant. The disclosure was made on ...